Lumryz Gains Ground in Narcolepsy Treatment, Reports Avadel

Avadel Pharmaceuticals shared updates on the performance and reception of its new narcolepsy medication, Lumryz.

Related Keywords

Greg Divis , Emisar Optum , Avadel Pharmaceuticals , Lumryz Risk Evaluation , Mitigation Strategy , Orphan Drug Exclusivity , Optum Select , Supplemental New Drug Application ,